| Product Name | MF | CAS | Details |
|---|
| DPP | C36H40Cl2N2O10Pt | 2668267-47-6 | Details |
| G43-C3-TEG | 2702262-15-3 | Details |
| Bcl-2-IN-11 | C45H49ClFN7O8S | 2760536-88-5 | Details |
| 6-Iodoamiloride | C6H8IN7O | 60398-23-4 | Details |
| NWP-0476 | C47H53ClN8O8S | 2290611-26-4 | Details |
| AMPA receptor modulator-6 | C24H36N2O4S2 | 516491-33-1 | Details |
| Tuberculosis inhibitor 7 | C21H18FN3O2S | 121041-20-1 | Details |
| TMV-IN-5 | C22H23N3S | 1207318-92-0 | Details |
| RSV L-protein-IN-3 | 868860-35-9 | Details |
| SARS-CoV-2-IN-43 | C16H12O3 | 31356-11-3 | Details |
| RSV L-protein-IN-2 | C32H36N4O5 | 774130-99-3 | Details |
| Homouridine | C10H14N2O6 | 30685-57-5 | Details |
| BI 7446 | C20H22FN9O10P2S2 | 2767011-00-5 | Details |
| BT424 | C22H15BCl2N2O2 | 2755180-37-9 | Details |
| IACS-52825 | C16H13F7N4O2 | 2640376-72-1 | Details |
| Anticancer agent 127 | C26H37FN4O6S | 2410953-19-2 | Details |
| Anticancer agent 128 | 2941243-62-3 | Details |
| PD-1/PD-L1-IN-34 | 2924403-17-6 | Details |
| CDD-1819 | 2894104-40-4 | Details |
| Antitumor agent-114 | 2757762-91-5 | Details |
| RET-IN-24 | C27H26F2N8O | 2583767-68-2 | Details |
| KRAS degrader-1 | C55H57Br2ClFIN8O7 | 2795275-59-9 | Details |
| Anticancer agent 121 | 2924532-47-6 | Details |
| ATR-IN-29 | C19H22N8O | 2761193-67-1 | Details |
| Immuno modulator-1 | C32H31FN6O4 | 2757469-20-6 | Details |
| Tuberculosis inhibitor 8 | C21H19FN4O | 141353-07-3 | Details |
| DNA-PK-IN-10 | 2919315-89-0 | Details |
| JAK-IN-27 | C20H21F2N7O | 2673176-36-6 | Details |
| CDD-1733 | 2894104-33-5 | Details |
| 1-Isopropyltryptophan | 1219485-46-7 | Details |
| Anticancer agent 122 | C18H15ClN2O2S | 2924532-50-1 | Details |
| MC-VC-PAB-Cyclohexanediamine-Thailanstatin A | C63H91N9O16 | 1609108-96-4 | Details |
| DQn-1 | C16H14ClN5O2 | 57343-54-1 | Details |
| CDD-1845 | C34H31N5O2 | 2894104-50-6 | Details |
| Topoisomerase II inhibitor 15 | 451516-79-3 | Details |
| Tuberculosis inhibitor 6 | C21H19N3O2S | 121041-08-5 | Details |
| HDAC8-IN-4 | C17H14N2O2S2 | 1600528-05-9 | Details |
| Estrogen receptor modulator 7 | 2639168-13-9 | Details |
| FD1024 | C21H20F2N4O2S | 1422456-47-0 | Details |
| ER degrader 7 | 2922929-63-1 | Details |
| Antibacterial agent 154 | 2163048-45-9 | Details |
| M867 | C27H43N7O6 | 680999-39-7 | Details |
| GPR119 agonist 2 | C23H24FN5O4S2 | 1384951-03-4 | Details |
| DCLK1-IN-2 | C26H32N8O3S | 2978517-43-8 | Details |
| HL23 | C44H44N2O7 | 1448355-15-4 | Details |
| Tankyrase-IN-5 | C17H18N2O2 | 1460285-69-1 | Details |
| MK-8768 | C21H22F3N5O2 | 1432729-22-0 | Details |
| SDH-IN-3 | C15H11F2N3OS | 2805297-11-2 | Details |
| Antitumor agent-104 | C31H33FN6O3 | 2245272-16-4 | Details |
| PPARγ agonist 8 | 1049800-41-0 | Details |
| mTOR inhibitor-11 | C21H26N6O2 | 3033409-32-1 | Details |
| WM-586 | C20H20F3N5O3S | 2894832-05-2 | Details |
| BTK-IN-25 | 2562351-92-0 | Details |
| CDK4/6-IN-17 | C27H28F4N8 | 2035069-96-4 | Details |
| ER degrader 6 | 2922929-62-0 | Details |
| IIIM-8 | C14H17NO4 | 1128053-62-2 | Details |
| AMPA receptor modulator-5 | C20H12F4N6 | 2034182-22-2 | Details |
| YXG-158 | C30H36FN3O | 2952994-34-0 | Details |
| Antifungal agent 66 | 1613152-33-2 | Details |
| 22-(4′-py)-JA | 1178895-15-2 | Details |
| Leucettinib-92 | C21H22N4OS | 2732859-57-1 | Details |
| Sirt1/2-IN-2 | C18H14N4O3S2 | 670267-73-9 | Details |
| CFTR corrector 12 | C19H21ClN4O2S2 | 958941-60-1 | Details |
| Y18501 | 2410627-32-4 | Details |
| Antitrypanosomal agent 14 | C14H23N3OS | 1447933-37-0 | Details |
| SP-2-225 | C28H34N2O3 | 2364448-93-9 | Details |
| HIV-1 protease-IN-9 | 2925381-27-5 | Details |
| PROTAC IRAK4 degrader-8 | C43H50ClF2N11O5 | 2911615-06-8 | Details |
| Syk-IN-8 | C23H26N10 | 2568963-01-7 | Details |
| CaSR antagonist-1 | C29H24FN3O2S | 1219811-83-2 | Details |
| CT1113 | C25H29N5O2S | 2523435-18-7 | Details |
| GLX481304 | C23H29N7O | 701224-63-7 | Details |
| FEN1-IN-6 | C12H8N2O5S2 | 824983-84-8 | Details |
| PROTAC KRAS G12C degrader-3 | C63H75ClN14O6 | 2768099-51-8 | Details |
| RSV L-protein-IN-5 | 851658-28-1 | Details |
| KRAS G12D modulator-1 | 2883034-05-5 | Details |
| JAK1-IN-11 | C26H36N6O4S | 2427608-43-1 | Details |
| Estrogen receptor modulator 8 | 2170766-56-8 | Details |
| JAK1-IN-10 | 2416858-88-1 | Details |
| ROCK-IN-7 | C17H17N3O2S | 2376635-95-7 | Details |
| MOR agonist-1 | C22H26ClFN2O2 | 2305781-14-8 | Details |
| CDK9-IN-23 | C22H25ClN4O3 | 2761572-96-5 | Details |
| CBP/p300-IN-21 | C19H16NO4.Cl | 1065581-69-2 | Details |
| CDK4-IN-2 | 2380320-68-1 | Details |
| TRPC3/6-IN-2 | 2387893-55-0 | Details |
| PRMT5-IN-28 | C18H19ClN4O5 | 2242753-66-6 | Details |
| IpOHA | C5H9NO4 | 132418-03-2 | Details |
| Hedgehog IN-2 | 1126365-74-9 | Details |
| PCSK9-IN-14 | C15H10F6N4O2 | 2913198-84-0 | Details |
| TRV-1387 | C23H25F3N4O2 | 1569645-63-1 | Details |
| AXL-IN-15 | 1954722-22-5 | Details |
| BACE1-IN-13 | C20H17FN8O2 | 1397683-26-9 | Details |
| PCSK9-IN-15 | 2455423-94-4 | Details |
| Orexin receptor modulator-1 | 2125735-57-9 | Details |
| Androgen receptor-IN-5 | C22H10Cl2F4N4OS | 1391944-16-3 | Details |
| ATR-IN-21 | C23H27N7O | 2905312-17-4 | Details |
| 3′-Acetate-ATP | C12H18N5O14P3 | 90290-58-7 | Details |
| USP7-IN-12 | C29H28ClFN4O2S | 2763698-01-5 | Details |
| THR-β modulator-1 | 2770373-00-5 | Details |
| ATR-IN-22 | C25H31N7O | 2905312-07-2 | Details |
| Product Total： Product Page： | ||||
| 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 | ||||